Connect with us

Technology

Circadian Health and Tenovi Announce Strategic Partnership to Expand Remote Patient Monitoring for Chronic Disease Management

Published

on

Collaboration Integrates Next-Generation Remote Patient Monitoring Devices into Circadian’s Virtual Specialty Care Platform, Enhancing Patient Outcomes and Reducing Costs

WEST PALM BEACH, Fla., March 11, 2025 /PRNewswire/ — Circadian Health, the first and only virtual-first provider specializing in cardiometabolic care across all 50 states, today announced a strategic partnership with Tenovi, a leading provider of over 40 next-generation cellular-connected remote patient monitoring (RPM) and remote therapeutic monitoring (RTM) devices. As Circadian continues to rapidly scale its virtual-first specialty care model, the addition of Tenovi’s advanced RPM solutions will further support the growing demand for seamless, real-time remote patient care. This collaboration enhances Circadian’s hospital-at-home model, empowering payers and employers to expand chronic disease management, drive earlier interventions, and improve patient outcomes.

Tenovi’s healthcare IoT platform and Cellular Gateway facilitate seamless connectivity for a wide range of cellular and Bluetooth-enabled RPM and RTM devices. These devices automatically transmit real-time patient data to the Tenovi Cloud, eliminating the need for syncing or apps. This cellular-based connectivity ensures that even patients facing housing instability can engage in remote monitoring programs, breaking down barriers to care. Circadian will roll out its RPM program with devices such as blood pressure monitors, blood glucose meters, weight scales, and pulse oximeters. The data collected is then integrated into Circadian’s virtual specialty care platform, providing specialists with real-time, actionable insights to enhance patient care and reduce costly hospital admissions.

“Circadian is committed to revolutionizing chronic care by integrating cutting-edge remote monitoring technology into our virtual-first specialty care model. Our partnership with Tenovi ensures that patients receive real-time, data-driven care, reducing emergency visits and improving long-term outcomes,” said Chuck Hector, Co-Founder and President of Circadian Health. “With seamless data transmission and AI-driven risk stratification, we are taking a proactive approach to cardiometabolic care, making high-quality specialty care more accessible, efficient, and impactful.”

Tenovi’s remote monitoring solutions make preventive care accessible to every patient population by enabling seamless, reliable monitoring. The Cellular Gateway supports a range of devices and reinforces adherence with visual reminders. Each morning, the Tenovi Gateway turns red to remind patients to take a reading and green once the measurement is transmitted—keeping them engaged and connected to their healthcare team in seconds.

“Through our partnership with Circadian, we help patients with chronic conditions like diabetes, heart failure, and COPD access timely specialty care, avoiding the long wait times that are a major contributor to costly hospital admissions,” said Iftah Mashav, Chief Growth Officer at Tenovi. “By integrating Circadian’s virtual care network with our cellular-connected devices and IoT Healthcare platform, we are empowering patients, health plans, and employers to reduce overall healthcare costs while enhancing health outcomes.”

With next-generation remote monitoring technology, Circadian and Tenovi are transforming specialty care by enabling seamless, real-time data transmission—helping payers and employers scale remote monitoring, drive earlier interventions, and improve patient outcomes.

40+ devices enable payers and employers to scale remote monitoring programs.No syncing. No apps—real-time data transmission via Tenovi’s Cellular Gateway.Single API integration streamlines data collection and enhances care coordination.FDA-cleared, cellular-enabled RPM & RTM devices provide real-time patient vitals.Circadian’s AI-driven platform delivers actionable insights for proactive disease management.Improved patient outcomes through early intervention and personalized treatment.

About Circadian Health
Circadian Health is revolutionizing chronic care management as the first and only virtual-first provider specializing in cardiometabolic care across all 50 states. Through AI-driven risk stratification, remote monitoring, and virtual access to top specialists, Circadian ensures timely, high-quality specialty care for heart failure, diabetes, and sleep disorders. With a hospital-at-home model, interoperable technology, and a commitment to health equity, Circadian is shaping the future of chronic disease management. For more information, visit www.circadiancare.com and follow us on LinkedIn at Circadian Health.

About Tenovi
Tenovi is a data aggregation and automation Healthcare IoT platform that connects medical device manufacturers with remote patient monitoring companies. It provides over 30 medical device point solutions that integrate with its proprietary Cellular Gateway, automating the transfer of patient vitals. Tenovi’s API-driven fulfillment and automation services enable seamless deployment of remote patient and therapeutic monitoring programs. For more information, visit www.tenovi.com.     

View original content to download multimedia:https://www.prnewswire.com/news-releases/circadian-health-and-tenovi-announce-strategic-partnership-to-expand-remote-patient-monitoring-for-chronic-disease-management-302397024.html

SOURCE Circadian Health

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Smartkem to Participate at SEMICON® China 2025

Published

on

By

MANCHESTER, England, March 19, 2025 /PRNewswire/ — Smartkem (Nasdaq: SMTK), which is seeking to change the world of electronics with a new class of transistor technology, announced it will participate at SEMICON® China, being held at the Shanghai New International Expo and taking place on March 26-28, 2025.

Smartkem’s Head of Business Development Michelle Ouyang will be in attendance throughout the conference to explore potential customer engagements and will be available for 1-on-1 meetings with industry representatives. To arrange a meeting, please contact Michelle at m.ouyang@smartkem.com

For more information on SEMICON China, please visit: SEMICON China信息网站

About Smartkem
Smartkem is seeking to change the world of electronics with a new class of transistor using its proprietary advanced semiconductor materials that have the potential to revolutionize the display industry. Smartkem’s TRUFLEX® semiconductor technology enables low temperature printing processes that are compatible with existing manufacturing infrastructure with the potential to deliver low-cost, high performance displays in a range of display technologies including microLED, miniLED and AMOLED, as well as applications in sensors and logic.

Smartkem develops its materials at its research and development facility in Manchester, UK and provides prototyping services at the Centre for Process Innovation (CPI) at Sedgefield, UK. It has a field application office in Taiwan. The company has an extensive IP portfolio including 138 granted patents across 17 patent families, 17 pending patents and 40 codified trade secrets. For more information, visit our website or follow us on LinkedIn.

Forward-Looking Statements
All statements in this press release that are not historical are forward-looking statements, including, among other things, its market position and market opportunity, expectations and plans as to its product development, manufacturing and sales, and relations with its partners and investors. These statements are not historical facts but rather are based on Smartkem, Inc.’s current expectations, estimates, and projections regarding its business, operations and other similar or related factors. Words such as “may,” “will,” “could,” “would,” “should,” “anticipate,” “predict,” “potential,” “continue,” “expect,” “intend,” “plan,” “project,” “believe,” “estimate,” and other similar or elated expressions are used to identify these forward-looking statements, although not all forward-looking statements contain these words. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, and assumptions that are difficult or impossible to predict and, in some cases, beyond the Company’s control. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described in the Company’s filings with the Securities and Exchange Commission. The Company undertakes no obligation to revise or update information in this release to reflect events or circumstances in the future, even if new information becomes available.

Contacts: 
Selena Kirkwood
Head of Communications for Smartkem 
T: +44 (0) 7971 460 364
s.kirkwood@smartkem.com

U.S. Investors 
David Barnard, CFA 
Alliance Advisors Investor Relations 
T: 1 415 433 3777 
dbarnard@allianceadvisors.com

Logo – https://mma.prnewswire.com/media/2597198/5222428/SmartKem_Brand_Identity_RGB_POS___small_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/smartkem-to-participate-at-semicon-china-2025-302404925.html

Continue Reading

Technology

FRONTSTEPS FORWARD 2025: THE DEFINITIVE EVENT SHAPING THE FUTURE OF COMMUNITY MANAGEMENT

Published

on

By

The Must-Attend Event for Community Management Leaders, Showcasing AI, Automation, and the Future of Property Technology

VAIL, Colo., March 19, 2025 /PRNewswire/ — In an era where technology is reshaping how communities are managed, FRONTSTEPS FORWARD 2025 (www.frontstepsforward.com) stands as the premier gathering for industry leaders, property managers, and tech innovators looking to define the future. Hosted by FRONTSTEPS (www.frontsteps.com), the nation’s leading HOA and property management solutions provider, this groundbreaking event will showcase the most cutting-edge advancements in AI-driven automation, cybersecurity, resident engagement, and operational efficiency.

Why FRONTSTEPS FORWARD 2025 is Unmissable
With 370,000 HOAs managing over 74 million residents across the U.S., the industry is at a critical turning point. Aging management systems, rising resident expectations, and increasing compliance challenges demand bold, tech-driven solutions. FRONTSTEPS FORWARD 2025 will be the definitive platform for unveiling the latest innovations and strategic insights to navigate these challenges head-on.

What Attendees Can Expect:

AI & Automation in Property Management – See firsthand how AI is revolutionizing community operations, from predictive maintenance to automated resident services.Exclusive Technology Announcements – Be the first to experience FRONTSTEPS’ latest software advancements designed to improve efficiency and security for community managers.High-Impact Educational Sessions – Expert-led discussions on digital transformation, compliance updates, and cybersecurity for HOAs and property managers.Elite Networking Opportunities – Connect with top executives, real estate innovators, and industry pioneers driving change.Vail: A Premier Event Destination – A unique experience where business meets luxury, offering attendees unparalleled networking opportunities in a breathtaking setting.

Who Should Attend?

Community managers, HOA board members, and property management professionals seeking to implement future-proof strategies.Real estate developers and investors looking to understand how emerging tech will impact community management.Tech innovators and service providers eager to connect with key decision-makers in property management.

Secure Your Spot Now

With limited availability, registration is now open for those ready to shape the future of community management. Sign up today at www.frontstepsforward.com.

About FRONTSTEPS:
FRONTSTEPS is the industry’s leading provider of HOA and property management technology, empowering thousands of communities across the U.S. to streamline operations, enhance security, and improve resident communication. With a strong focus on innovation, FRONTSTEPS continues to drive the evolution of community management technology.

Visit www.frontsteps.com to learn more.

For media inquiries, interviews, or sponsorship opportunities, please contact:

Media Contact: Emily Wigdale
ewigdale@frontsteps.com
(414) 801-1474
FRONTSTEPS

This press release was issued through 24-7PressRelease.com. For further information, visit http://www.24-7pressrelease.com.

View original content:https://www.prnewswire.com/news-releases/frontsteps-forward-2025-the-definitive-event-shaping-the-future-of-community-management-302405537.html

SOURCE FRONTSTEPS

Continue Reading

Technology

Indero Marks 40th Study Live with Veeva RTSM

Published

on

By

Specialized CRO standardizes on Veeva RTSM to drive operational efficiency and faster study timelines

BARCELONA, Spain, March 19, 2025 /PRNewswire/ — Veeva Systems (NYSE: VEEV) today announced that Indero, formerly Innovaderm Research, successfully launched its 40th RTSM study on Veeva RTSM. By standardizing with Veeva RTSM, Indero has strengthened its clinical trial operations, harnessing advanced RTSM capabilities and expert support to drive efficiency, enhance process consistency, and streamline execution.

“As we continue to optimize our clinical trial operations, Veeva RTSM has driven more efficient processes and closer collaboration to ensure seamless execution,” said Eric Hardy, senior director, biometrics at Indero. “Because of this added speed and effectiveness, we can help bring therapies to market faster, allowing our sponsors, sites, and patients to benefit sooner.”

The launch of Indero’s 40th RTSM study highlights the continued collaboration between the two organizations. Since first adopting Veeva RTSM, Indero has worked closely with Veeva to continuously refine and implement standardized processes that drive long-term success for its clinical trials.

“With its enterprise standard RTSM approach, Indero is achieving greater long-term efficiency and reliability in their studies,” said Steve Simmerman, general manager, Veeva RTSM. “Partnering with Indero to standardize clinical processes will further accelerate study timelines, demonstrating a streamlined approach that can advance the industry.” 

Additional Information
To learn more about Veeva’s enterprise standard RTSM, visit www.veeva.com/rtsm.

About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world’s largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com/eu.

Veeva Forward-looking Statements
This release contains forward-looking statements regarding Veeva’s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10- Q for the period ended October 31, 2024, which you can find here (a summary of risks which may impact our business can be found on pages 36 and 37), and in our subsequent SEC filings, which you can access at sec.gov.

Contact:

Jeremy Whittaker
Veeva Systems
+49-695-095-5486
jeremy.whittaker@veeva.com

Logo – https://mma.prnewswire.com/media/1488285/Veeva_Systems_Logo_v2.jpg

View original content:https://www.prnewswire.co.uk/news-releases/indero-marks-40th-study-live-with-veeva-rtsm-302405349.html

Continue Reading

Trending